RecruitingPhase 4NCT06278987

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture


Sponsor

University of Minnesota

Enrollment

150 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria1

  • Patients undergoing hip fracture repair aged 18-85.

Exclusion Criteria4

  • Patients who have an exclusion to regional anesthesia.
  • Patients who are pregnant assessed via self-report or pregnancy test if they have taken one.
  • Non-English speakers
  • Patients who already had their fracture repaired"

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPENG block and cryoablation

will receive an ultrasound guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves.

DRUGfascia iliaca compartment block

will receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour


Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06278987


Related Trials